Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study of [S,S]-Reboxetine Administered Once Daily in Patients With Fibromyalgia

NCT00357825 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00357825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00357825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study of [S,S]-Reboxetine Administered Once Daily in Patients With Fibromyalgia
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2006
Completion date
March 31, 2007
Enrollment
246
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

pain